Overview
Veloxity Labs is a bioanalytical CRO specializing in LC-MS/MS analysis for small molecules, peptides, and proteins from discovery through GLP/GCP-regulated clinical studies. They offer high-sensitivity methods, microsampling technology, and proprietary AI-powered automation (VELO™) to accelerate drug development while adhering to GLP, GCP, and ICH M10 standards. Based in Peoria, Illinois, their 48,000 sq. ft. facility supports both regulated and non-regulated testing, with recent acquisition of the SCIEX ZenoTOF 8600 system enhancing peptide and complex bioanalysis.
Frequently asked questions
- What bioanalytical capabilities does Veloxity Labs offer?
- Veloxity Labs provides LC-MS/MS analysis optimized for small molecules, therapeutic peptides, and proteins, supporting high-throughput workflows from discovery to GLP/GCP-regulated studies with high sensitivity and matrix-specific strategies.
- What regulatory standards does Veloxity Labs comply with?
- Veloxity Labs adheres to GLP, GCP, and ICH M10 international standards, delivering non-regulated and regulated bioanalysis with accuracy ensured by microsampling and proprietary automation.
- Where are Veloxity Labs facilities located and what is their capacity?
- Veloxity Labs operates a purpose-built 48,000 sq. ft. LC-MS laboratory in Peoria, Illinois, centralizing regulated and non-regulated testing, with recent 50% growth and expansion.